Composition for cushions, wounds dressings and other skin-contacting products
View Patent ↗A skin-contacting adhesive composition is described which has improved initial tack, long-term adhesion, water uptake and translucency characteristics and may be prepared by melt extrusion. Uses of these compositions are also described, for example, their use in wound dressings, adhesive cushions, and transdermal drug delivery devices.
1. A transdermal drug delivery device comprised of a therapeutically effective amount of an active agent, an outwardly facing backing layer, and a skin-contacting adhesive composition, wherein the adhesive composition comprises:
(a) a hydrophobic phase comprising a hydrophobic polymer, at least one elastomeric plasticizer and a tackifying resin; and
(b) a hydrophilic phase comprising:
i) at least one material selected from the group consisting of low molecular weight cellulose derived polymers and naturally occurring polysaccharides;
ii) at least one high molecular weight cellulose derived polymer; and
iii) reinforcing clay particles.
2. The transdermal drug delivery device of claim 1 wherein the hydrophobic polymer is selected from the group consisting of butadiene acrylonitrile rubber, butyl rubbers, ethylene-propylene-diene terpolymers, isobutylene-isoprene copolymers, natural rubber adhesives, polychloroprenes, polyisobutylenes, polyisoprenes, polysiloxanes, styrene-butadiene-styrene block copolymers, styrene-isoprene-styrene block copolymers, vinyl ether polymers, and combinations thereof.
3. The transdermal drug delivery device of claim 1 wherein the high molecular weight cellulose derived polymers are selected from the group consisting of hydroxypropylcellulose, hydroxypropylmethylcellulose and sodium carboxymethylcellulose.
4. The transdermal drug delivery device of claim 1 wherein the hydrophilic phase comprises at least one low molecular weight cellulose derived polymer selected from the group consisting of hydroxypropylcellulose, hydroxypropylmethylcellulose and sodium carboxymethylcellulose.
5. The transdermal drug delivery device of claim 1 wherein the hydrophilic phase comprises at least one naturally occurring polysaccharide selected from the group consisting of agars, alginates, carrageenans, chitin, chitosan, glucomannan, gum guar, gellan gum, locust bean gum, pectins, pullulan, starches and xanthans, and combinations thereof.
6. The transdermal drug delivery device of claim 1 wherein the clay particles are comprised of montmorillonite.
7. The transdermal drug delivery device of claim 1 further comprising a drug reservoir containing at least a portion of the therapeutically effective amount of active agent which is separate from the skin-contacting adhesive.
8. The transdermal drug delivery device of claim 7 wherein the skin-contacting adhesive composition serves as the drug reservoir.
9. The transdermal drug delivery device of claim 1 which further comprises a rate controlling membrane.